#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gastrooesophageal cancer Epstein-Barr virus infection Proteus syndrome Pituitary-dependent Cushing's syndrome HER2 gene amplification Deafness neurosensory Sarcoma Spinal muscular atrophy Lymphangiosarcoma Metastatic gastric cancer Hypoxic-ischaemic encephalopathy Pleomorphic liposarcoma Cystic fibrosis gastrointestinal disease Astrocytoma Cholangiosarcoma More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia refractory – Trials in Disease Undifferentiated sarcoma Mantle cell lymphoma stage III – Trials in Disease Glomerulonephritis membranous – Trials in Disease Chordoma – Diagnostics Lysosomal storage disorder – Diagnostics Testicular leiomyosarcoma – Treatment Immunodeficiency congenital – Basic Information Hereditary neuropathic amyloidosis – Life with Disease Tuberous sclerosis complex – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bepranemab Lanifibranor Artemisia Vulgaris Doxazosin Levonorgestrel Methylphenidate Hydrochloride Losartan Potassium Entrectinib Caspofungin Acetate LYSERGIDE HALOBETASOL PROPIONATE IDP-121 Febuxostat Hemihydrate Bromhexine Hydrochloride VMX-C001 Fluorouracil Mbs2320 Mifamurtide Loratadine Ambrosia Artemisiifolia (302) More therapies…

    Learn about Your Condition

    Partial seizures Gastric cancer Lymphoma Pneumonia bacterial Skin bacterial infection Cervical dysplasia Osteotomy Henoch-Schonlein purpura Pathogen resistance Small intestine leiomyosarcoma Hepatitis B Anal fistula Hypogonadism male Exudative retinopathy Epithelioid sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study on the Effectiveness of Eltrombopag in Combination with Other Drugs for Patients with Immune Thrombocytopenia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • Avatrombopag
    • Eltrombopag
    • Ciclosporin
    Czechia

  • Study on Luspatercept for Treating Anemia in Adults and Adolescents with Alpha-Thalassemia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Thalassaemia alpha
    Investigated Drugs:
    • Luspatercept
    Greece Italy

  • Study on TAK-330 for Reversing Anticoagulation in Patients on Factor Xa Inhibitors Needing Urgent Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Thrombosis prophylaxis
    Investigated Drugs:
    • Human Coagulation Factor Ii
    • Human Coagulation Factor Ix
    • Human Coagulation Factor Vii
    Austria Belgium Czechia France Germany Greece +5

  • Study of Cytarabine and Daunorubicin for Treating Myeloid Leukemia in Children with Down Syndrome

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Trisomy 21
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Cytarabine
    • Daunorubicin
    Austria Belgium Czechia Germany Italy The Netherlands +1

  • Study of Glofitamab with Rituximab or Obinutuzumab and Drug Combination for Untreated Richter’s Syndrome Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Richter’s syndrome
    Investigated Drugs:
    • Glofitamab
    • Obinutuzumab
    • Cyclophosphamide
    France

  • Study on Tocilizumab for Treating Acute Chest Syndrome in Children and Adults with Sickle Cell Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Sickle cell disease
    Investigated Drugs:
    • Sodium Chloride
    • Tocilizumab
    France
Previous Page
1 … 31 32 33 34 35 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!